Healthcare Sales & Marketing Network News: ChemoFx

Searching News Database: ChemoFx

HSMN NewsFeed - 11 Mar 2013
Precision Therapeutics Announces Topline Prospective Clinical Data Demonstrating Significant Improvement in Overall Survival and Progression Free Survival in Recurrent Ovarian Cancer using Personalized Chemotherapy Diagnostic ChemoFx(R)
Diagnostics Oncology Personalized Medicine

HSMN NewsFeed - 24 Jan 2012
Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care
Diagnostics Oncology Personalized Medicine

HSMN NewsFeed - 19 Jan 2011
Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing the Utility of ChemoFx(R) in Cancer Treatment Options
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 1 Jun 2009
Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients
Diagnostics Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Nov 2008
Precision Therapeutics Secures $43 Million in Venture Capital Funding
Diagnostics Venture Capital

HSMN NewsFeed - 4 Dec 2007
Oracle Healthcare Acquisition Corp. and Precision Therapeutics Announce Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.